Literature DB >> 10817621

BN 80933 inhibits F2-isoprostane elevation in focal cerebral ischaemia and hypoxic neuronal cultures.

J G Marin1, S Cornet, B Spinnewyn, C Demerlé-Pallardy, M Auguet, P E Chabrier.   

Abstract

Formation of the lipid peroxidation product 8-epi-prostaglandin2alpha (8-epi-PGF2alpha) a bioactive marker of oxidative stress, was quantified in in vitro and in vivo models of neuronal death. In culture media of primary rat cortical neurones exposed to hypoxia followed by reoxygenation, a 3.7-fold increase of 8-epi-PGF2alpha concentration was observed in comparison to control cells. In rats submitted to 2h middle cerebral artery occlusion followed by a 22h reperfusion period, a 27-fold increase of 8-epi-PGF2alpha was observed in the ischaemic hemisphere compared with the corresponding hemisphere of sham-operated rats. Treatment with the neuroprotective agent BN 80933 significantly reduced both 8-epi-PGF2alpha elevations in vitro and in vivo. These data suggest that 8-epi-PGF2alpha elevations might reflect the damaging free radical overproduction and subsequent lipid peroxidation during neuronal injury induced by hypoxia and ischaemia. Inhibition of 8-epi-PGF2alpha elevations participates to the neuroprotective effects of BN 80933.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817621     DOI: 10.1097/00001756-200004270-00041

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  6 in total

1.  Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration.

Authors:  Erik S Musiek; Rebecca S Breeding; Ginger L Milne; Giuseppe Zanoni; Jason D Morrow; Bethann McLaughlin
Journal:  J Neurochem       Date:  2006-04-21       Impact factor: 5.372

2.  Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning.

Authors:  Jacquelynn E Brown; Stephanie L H Zeiger; Jane C Hettinger; Joshua D Brooks; Benjamin Holt; Jason D Morrow; Erik S Musiek; Ginger Milne; Bethann McLaughlin
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

3.  LC/MS/MS method for analysis of E₂ series prostaglandins and isoprostanes.

Authors:  Stephen A Brose; Brock T Thuen; Mikhail Y Golovko
Journal:  J Lipid Res       Date:  2011-02-10       Impact factor: 5.922

4.  Neuroprotection by tamoxifen in focal cerebral ischemia is not mediated by an agonist action at estrogen receptors but is associated with antioxidant activity.

Authors:  Yonghua Zhang; Dejan Milatovic; Michael Aschner; Paul J Feustel; Harold K Kimelberg
Journal:  Exp Neurol       Date:  2007-01-24       Impact factor: 5.330

5.  Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury.

Authors:  Stephanie L H Zeiger; Erik S Musiek; Giuseppe Zanoni; Giovanni Vidari; Jason D Morrow; Ginger J Milne; BethAnn McLaughlin
Journal:  Free Radic Biol Med       Date:  2009-08-19       Impact factor: 7.376

6.  Formation of eicosanoids, E2/D2 isoprostanes, and docosanoids following decapitation-induced ischemia, measured in high-energy-microwaved rat brain.

Authors:  Santiago E Farias; Mireille Basselin; Lisa Chang; Kim A Heidenreich; Stanley I Rapoport; Robert C Murphy
Journal:  J Lipid Res       Date:  2008-05-23       Impact factor: 5.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.